should i take glp 1 for weight loss GLP-1 Medications: Everything You Need to Know Comparing GLP‑1 Drugs With Other

lira: liraglutide

Skin Health: Antioxidants help combat the effects of environmental stressors on the skin, supporting a natural, healthy glow

Would you project that's going to be possible in the years ahead

WEDNESDAY, July 23, 2025 (HealthDay News) -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin, according to a study published online July 22 in BMJ Open Diabetes Research & Care.Mingyang Sun, from the People's Hospital of Zhengzhou University in China, and colleagues conducted a retrospective cohort study using data from a global health research network between 2004 and 2024 to examine the comparative effectiveness of GLP-1 RAs and metformin in reducing dementia risk